Roberts Anjeanette, Lamirande Elaine W, Vogel Leatrice, Jackson Jadon P, Paddock Christopher D, Guarner Jeannette, Zaki Sherif R, Sheahan Timothy, Baric Ralph, Subbarao Kanta
Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, MD, United States.
Virus Res. 2008 Apr;133(1):20-32. doi: 10.1016/j.virusres.2007.03.025. Epub 2007 May 11.
We summarize findings of SARS-CoV infections in several animal models each of which support viral replication in lungs accompanied by histopathological changes and/or clinical signs of illness to varying degrees. New findings are reported on SARS-CoV replication and associated pathology in two additional strains (C57BL/6 and 129S6) of aged mice. We also provide new comparative data on viral replication and associated pathology following infection of golden Syrian hamsters with various SARS-CoV strains and report the levels of neutralizing antibody titers following these infections and the cross-protective efficacy of infection with these strains in protecting against heterologous challenge. Finally, we summarize findings of a variety of vaccine approaches and discuss the available in vitro and in vivo data addressing the potential for disease enhancement following re-infection in animals previously vaccinated against or infected with SARS-CoV.
我们总结了SARS-CoV在几种动物模型中的感染结果,每种模型都在不同程度上支持病毒在肺部复制,并伴有组织病理学变化和/或疾病的临床症状。报告了另外两种老年小鼠品系(C57BL/6和129S6)中SARS-CoV复制及相关病理学的新发现。我们还提供了关于不同SARS-CoV毒株感染金黄叙利亚仓鼠后病毒复制及相关病理学的新比较数据,并报告了这些感染后的中和抗体滴度水平以及这些毒株感染在抵抗异源攻击方面的交叉保护效力。最后,我们总结了各种疫苗方法的研究结果,并讨论了现有的体外和体内数据,这些数据涉及曾接种过针对SARS-CoV的疫苗或感染过SARS-CoV的动物再次感染后疾病增强的可能性。